Table 1 Potency and selectivity of cyclic peptide hits from the RaPID system.

From: Highly selective inhibition of histone demethylases by de novo macrocyclic peptides

 

IC 50 (nM)

 

D Tyr-Library

L Tyr-Library

 

CP1

CP2

CP3

CP4

CP5

KDM4A

>105

42

>105

20

313

KDM4B

33

6

472

KDM4C

39

>105

17

123

KDM4D

6,270

6,260

>104

KDM4E

9,200

4,700

8,900

KDM2A

>104

>104

>104

KDM3A

>104

9,900

>104

KDM5C

>104

>104

>104

KDM6B

6,800

7,200

>104

KDM1A

>104

>104

>104

PHD2

>106

>106

>106

FIH

>106

>106

>106

KDM4A Binding

Kd (nM)

 

29.8

 

36.0

173

kon (1/Ms)

 

1.37 × 105

 

2.18 × 104

6.2 × 104

kdiss (1/s)

 

4.07 × 10−3

 

7.84 × 10−4

1.07 × 10−2

  1. 2OG, 2-oxoglutarate; FIH, factor inhibiting HIF; IC50, half-maximal inhibitory concentration; KDM, histone demethylase; LSD, lysine-specific demethylase; MALDI–TOF, matrix-assisted laser desorption/ionization–time of flight; MS, mass spectrometry; PHD2, prolyl hydroxylase domain 2; RaPID, Random nonstandard Peptides Integrated Discovery.
  2. KDM IC50 values were determined using AlphaScreen, except for KDM1A/LSD1 where a fluorescence-based assay was used. MALDI–TOF MS assays were used for counterscreening against other 2OG oxygenases. Binding constants for KDM4A were measured using biolayer interferometry.